Financial Ratios

CASIL HEALTH PRODUCTS LTD.

NSE : NABSE : 523254ISIN CODE : Industry : Medical Equipment/Supplies/AccessoriesHouse : Private
BSE57.500 (0 %)
PREV CLOSE ( ) 57.50
OPEN PRICE ( ) 62.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )57.50 64.75
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2017Mar2016Mar2015Mar2014Mar2013
Operational & Financial Ratios
   Earnings Per Share (Rs)4.5436.1322.032.1123.36
   CEPS(Rs)5.1636.3422.033.0724.46
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-806.22-810.76-846.89-958.87-960.98
   Tax Rate(%)-4.0111.2625.976.908.46
Margin Ratios
   Core EBITDA Margin(%)1.7817.1512.911.2814.02
   EBIT Margin(%)1.7017.1312.911.0413.55
   Pre Tax Margin(%)1.7017.1212.901.0213.54
   PAT Margin (%)1.7715.199.550.9512.40
   Cash Profit Margin (%)2.0115.289.551.3812.98
Performance Ratios
   ROA(%)2.3622.5819.942.7833.86
   ROE(%)0.000.000.000.000.00
   ROCE(%)3.0933.6263.180.000.00
   Asset Turnover(x)1.331.492.092.932.73
   Sales/Fixed Asset(x)138.17211.187.166.06
   Working Capital/Sales(x)1.811.772.26-7.31-0.19
Efficiency Ratios
   Fixed Capital/Sales(x)0.010.000.000.140.17
   Receivable days79.0083.2589.2854.1222.39
   Inventory Days0.000.000.000.790.93
   Payable days6543.550.00
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)3.513.784.124.27-0.06
   EV/Core EBITDA(x)180.9521.9431.93290.66-0.45
   EV/EBIT(x)206.3122.0631.93411.31-0.47
   EV/CE(x)4.484.906.9611.28-0.18
   M Cap / Sales0.000.000.000.000.00
Growth Ratio
   Net Sales Growth(%)8.113.083.5518.234.92
   Core EBITDA Growth(%)-87.8137.55809.36-87.71-49.65
   EBIT Growth(%)-89.2536.841186.86-90.94-50.64
   PAT Growth(%)-87.4363.97944.06-90.97-48.86
   EPS Growth(%)-87.4363.97944.06-90.97-48.86
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)5.776.694.810.660.04
   Quick Ratio(x)5.776.694.810.650.04
   Interest Cover(x)395.101454.022477.0249.371471.30
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.